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Revised 12 March 2019Abstract
The phosphorylation of (+) alpha tocopherol produces adhesive nanostructures that interact with oral biofilms to restrict their growth. The aim
of this work was to understand if these adhesive (+) alpha tocopheryl phosphate (α-TP) nanostructures could also control macrophage responses to
the presence of oral bacteria. The (+) α-TP planar bilayer fragments (175 nm ± 21 nm) formed in a Trizma®/ethanol vehicle swelled when
exposed to the cell lines (maximum stabilized size = 29 μm). The swelled (+) α-TP aggregates showed selective toxicity towards THP-1
macrophages (LD50 = 304 μM) compared to human gingival fibroblasts (HGF-1 cells; LD50 N 5 mM), and they inhibited heat killed bacteria
stimulated MCP-1 production in both macrophages (control 57.3 ± 18.1 pg/mL vs (+) α-TP 6.5 ± 3.2 pg/mL) and HGF-1 cells (control
673.5 ± 133 pg/mL vs (+) α-TP - 463.9 ± 68.9 pg/mL).
© 2019 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).
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chemoattractant 1Macrophages perform a number of important regulatory
functions in the human body,1 but in several pathologies
including, malignant tumors,2 inflammatory disease,3 metabolic
disease,4 infections,5 and periodontitis,6 their dysfunction is
thought to contribute to disease progression.7 Anti-cytokine
therapies can act to counteract macrophage dysfunction, but their
‘off-target’ side-effects render the currently available agents
inappropriate for this indication.8 Macrophages are highly
mobile and thus they are difficult to specifically target through
traditional drug delivery approaches.9 However, their ability to
actively recognize and phagocytose foreign material provides aFunding information: The study was financed by an Engineering and
Physical Sciences Research Council (EPSRC) CASE award with Johnson
and Johnson. EPSRC had no role in study design, data collection and
interpretation, or the decision to submit the work for publication. Johnson and
Johnson had a role in some experimental design and data interpretation.
⁎Corresponding author at: King's College London, Institute of Pharma-
ceutical Science, London, SE1 9NH.
E-mail address: stuart.jones@kcl.ac.uk. (S.A. Jones).
https://doi.org/10.1016/j.nano.2019.04.013
1549-9634/© 2019 The Author(s). Published by Elsevier Inc. This is an open accpotential route to specifically deliver agents into macrophages
using bespoke drug carrier systems.
One class of lipids that have the potential to be formed into
materials that could target macrophages is the tocopherol lipids.10
In recent work a novel tocopherol analogue, (+) alpha tocopheryl
phosphate (α-TP)was synthesized andwas shown to formoral bio-
retentive nanomaterials that disrupt biofilm growth.11 In themouth
the ionic phosphate moiety of α-TP interacts with simple
electrolytes and this gives it the potential to swell and change
shape,12 which could facilitate macrophage phagocytosis and
release of the active from the nanomaterial structure. However, the
ability of α-TP nanomaterials to selectively target macrophage
responses in the mouth has yet to be tested.
In the mouth, macrophages and their cytokine products play
an important role, along with enzymes, in both periodontal soft
tissue and jawbone destruction.13 As a consequence, macro-
phages and the cytokines that stimulate macrophage recruitment
(e.g., MCP-114) have become targets in the search for new agents
to improve oral health.15 Therefore, the aim of this work was to
understand if (+) α-TP nanomaterials could be used to targetess article under the CC BY license (http://creativecommons.org/licenses/by/
2 R.A. Harper et al / Nanomedicine: Nanotechnology, Biology, and Medicine 21 (2019) 102010macrophage dysfunction in the mouth. It was predicted that the
surface charge and size of the aggregates would influence their
uptake into oral tissue; therefore, three types of tocopherol
aggregates were used in this study: (+) α-T, which was predicted
to display a neutral surface, and two structural isomers of α-TP,
the (+) isomer and (±) isomer , both of which were predicted to
be negatively charged in the mouth.Materials
(+) α-T (type (VI, ~40%), phosphorous oxychloride (POCl3)
(≥99%), tetrahydrofuran (THF) (anhydrous) (≥99.9%), triflour-
oacetic acid (TFA) (≥99%), (±) α-T (≥96%), Trizma®
hydrochloride (Tris(hydroxymethyl)aminomethane hydrochlo-
ride) (≥99%), (±) α-TP (≥97%), chlorhexidine digluconate
(CHX) (20% w/v aqueous solution), cetylpyridinium chloride
monohydrate (CPC) (99.0%-102%), Hanks Balanced Salt
Solution (HBSS) (cat. no. H6648), 2-mercaptoethanol (99%),
Dulbecco's Phosphate Buffered Saline (PBS) (cat. no. D8537),
trypan blue (0.4%), Phorbol 12-myristate 13-acetate (PMA)
(≥99%, film), trypsin–EDTA (0.25%) and TRI-Reagent®
(Ambion) where purchased from Sigma Aldrich, UK. Hexane
by fractions, absolute ethanol isopropanol, dimethyl sulfoxide
(DMSO), disodium hydrogen phosphate (≥99%), monosodium
dihydrogen phosphate (≥99%), hydrochloric acid, sodium
hydroxide, heat-inactivated fetal bovine serum (FBS), penicillin
G-streptomycin, MagMax™-96 for Microarrays Kit (Ambion,
AM1839), High-Capacity RNA-to-cDNA™ Kit (Applied Bio-
systems) and TaqMan Universal PCR Master Mix (Applied
Biosystems) were purchased from Fisher Scientific Ltd., UK.
De-ionized water was used from laboratory supply. Dulbecco's
modified Eagle's medium (DMEM) (ATCC 30-2002) cell
culture medium and HGF-1 (ATCC CRL-2014) cells were
purchased from the American Type Culture Collection (ATCC)
(USA). Roswell Park Memorial Institute (RPMI)-1640 Medium
(ATCC 30-2001) and the immortalized human peripheral blood
monocyte cell line THP-1 (ATCC TIB-202) were sourced from
LGC standards (UK). A colorimetric one step cell viability assay
using a novel tetrazolium compound [3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazo-
lium, inner salt; MTS] and an electron coupling reagent
(phenazine methosulfate; PMS) was purchased from Promega,
USA. This has been previously used to assess toxicity of zinc
oxide nanoparticles.16 Commercial enzyme-linked immunosor-
bent assays (ELISAs) including human MCP-1/CCL2, human
IL-8 and human IL-6 max deluxe sets were purchased from
Biolegend, USA. Disposable cuvettes (Macro, PMMA), tissue
culture flasks (25 and 75 cm2 with ventilated caps) and 96-well
plates where supplied by VWR (Germany).Methods
(+) α-TP synthesis
(+) α-TP synthesis used phosphorus oxychloride with
triethylamine in anhydrous THF for 3 h at room temperature
as previously described.11 The pure product was obtained afterC18 column chromatography. (+) α-TP was considered sterile
due to the presence of 70% isopropanol in the purification step.
Characterization of (+) α-T, (+) α-TP, (±) α-TP aggregates in
cell culture medium
The size of the aggregates was monitored in cell culture
media to mimic the gum tissue environment. The volume median
diameters of (+) α-T, (±) α-TP and (+) α-TP were measured using
a laser diffraction technique (Mastersizer X, version 2.15,
Malvern Instruments, UK). The vitamin E derivatives (3 mM)
dispersed initially in 20% ethanol, 80% water vehicles with
150 mM Trizma®. Samples were diluted in cell culture medium
(DMEM or RPMI without phenol red, FBS, or pen strep) to reach
an obscuration ca 20%. The volume median diameters were
recorded every 3 min for 15 min (N = 3).
Cultivation of gingival fibroblast cells and peripheral blood
monocyte cells
Two different cell lines HGF-1 and THP-1, important in gum
disease, were employed in the study.17,18 HGF-1 cells were
cultured in DMEM, which included 10% FBS, and 1% penicillin
G-streptomycin (complete media A). The immortalized human
peripheral blood monocyte cell line THP-1 was cultured in
RPMI-1640 medium, which included 10% FBS, 1% penicillin
G-streptomycin and 50 μM 2-mercaptoethanol (antioxidant)
(complete media B). Both cell lines were grown at 37 °C in a
5% CO2, humidified atmosphere until HGF-1 cells reached
confluence or until THP-1 monocytes reached 1 × 106 cell/mL.
HGF-1 cells were subcultured using trypsin–EDTA (0.25%)
(5 mL) and reseeded at 50% cell density (i.e. 1 flask of confluent
cells were split into 2 flasks). THP-1 monocytes were
subcultured every 2-3 days (not allowed to exceed 1 × 106
cell/mL) and were reseeded at 2 × 105 cells/mL. HGF-1 and
THP-1 cells used for experiments were between passages 3 and
8.
Preparation of heat killed bacteria
Oral heat killed bacteria were used to model the inflammatory
environment found in vivo.19,20 Human saliva (1 donor) was
collected, formed into bacterial pellets, re-suspended in cell
culture media (1 mL) (DMEM or RPMI-1640) and heat killed
using a heating block (Grant, QBA1 series), UK) at 80 °C for
10 min. The heat killed bacteria were diluted to 0.18 OD620 with
cell culture medium under sterile conditions followed by a 1/100
dilution of the solution in cell culture medium to form the
inflammatory stimuli.
Determination of HGF-1 and THP-1 cell line viability
The effects of (+)/(±) α-TP, (+) α-T and heat killed human
saliva bacteria, individually and in combination, were tested on
HGF-1 and THP-1 cells. CHX and CPC were also tested on
THP-1 macrophages as controls. To perform these assessments
HGF-1 cells (passages 3-8) were seeded (1 × 104 cells/well)21 in
96 well microplates (100 μL/well) and were incubated for 24 h
at 37 °C in a 5% CO2 atmosphere to allow for cell adhesion. The
culture medium was then aspirated, and the cells were treated for
4 h with (+) α-TP (0.05, 0.5, 5, 50, 500, or 5000 μM), (+) α-T
3R.A. Harper et al / Nanomedicine: Nanotechnology, Biology, and Medicine 21 (2019) 102010(500 or 5000 μM) or (±) α-TP (500 μM) (100 μL/well) after
which the test samples were aspirated and the cells washed with
HBSS (200 μL/well). Either complete media or heat killed
human bacteria from human saliva in complete media (1/100
dilution) were applied (100 μL/well) and the samples were
incubated for an additional 15 h at 37 °C in a 5% CO2
atmosphere. The THP-1 monocytes were seeded (1 × 104
cells/well) with PMA (5 ng/mL) to allow monocyte differenti-
ation and subsequent cell adhesion in 96 well microplates. They
were incubated for 48 h at 37 °C in a 5% CO2 atmosphere.
22 The
culture medium was aspirated; cells were washed with HBSS
and cultured in serum free media for 3 h. The cells were then
treated for 2 h (the time was reduced from 4 h to reduce the time
the cells were starved from FBS)23 with (+) α-TP (0.05, 0.5, 5,
50, 500, or 5000 μM), (±) α-TP (500 μM), (+) α-T (500 or
5000 μM), CHX (50, 100, 150, 500, or 5000 μM) or CPC (0.05,
0.5, 5, 50, or 500 μM) (100 μL/well) after which the test samples
were aspirated, and the cells washed with HBSS (200 μL/well).
Either complete media or heat killed human bacteria from
human saliva in complete media (1/100 dilution) were applied
(100 μL/well) and incubated for an additional 15 h at 37 °C in a
5% CO2 atmosphere. The 15 h supernatants were removed and
used for ELISA assays, fresh complete media (100 μL) were
added to the wells and then the colorimetric MTS tetrazolium
compound (20 μL) was added. Plates were then incubated at 37
°C in a 5% CO2 atmosphere for 4 h and then absorbances at
490 nm (iEMS Incubator/Shaker, Thermo Scientific, UK) were
measured with reference subtractions at 650 nm. Untreated
control cells were assigned a value of 100% viability (negative
control); cells treated with 1% triton X (dispersed in cell culture
media) were assigned a value of 0% viability (positive control).
All the other conditions were compared to the controls using Eq.
(1) were ABS was the corrected absorbance's. Results were
expressed as means ± standard deviations of triplicate assays
from three different experiments. Lethal dose 50% (LD50) values
were calculated using the dose response model in Origin 2016
(Silverdale scientific ltd, UK).
Cell viability %ð Þ
¼ ABSsample−ABSpositive control
ABSnegative control−ABSpositive control
 100 ð1Þ
Determination of cytokine secretion
MCP-1, IL-6 and IL-8 expression was measured in the
selected cell line supernatants in response to heat killed bacteria
and this was repeated in the presence of the tocopherols in order
to assess their anti-cytokine effects.24 ELISA kits were used to
quantify the protein concentrations of MCP-1, IL-8 and IL-6
produced in the microplate cell supernatants according to the
manufacturer's protocols. Preliminary experiments showed that
there was no detectable MCP-1 in the heat killed bacteria applied
to the cells and hence the detected MCP-1 was solely generated
from the HGF-1 cells. The test solutions at a concentration of
500 μM were not toxic against HGF-1 cells and hence this
concentration was selected to assess their effect on MCP-1
release.mRNA expression assay
mRNA transcript expression assays were performed using q-
PCR on HGF-1 cells to understand how MCP-1, IL-8 and IL-6
expression was being regulated in the presence and absence of
the three different tocopherol aggregates. The HGF-1 cells were
cultured and treated using the same method as the cell viability
assay with the exception that after the 15 h incubation with the
inflammatory stimuli supernatants were removed, and the cells
washed with PBS (100 μL/well) and then harvested with TRI-
Reagent® (100 μL/well). Cell treatments groups were in
quintuplet and were combined in microcentrifuge tubes
(500 μL, 50,000 cells) (N = 3). The total RNA was extracted
using MagMax™-96 for Microarrays Kit. RNA was quantified
using the NanoDrop (Thermo Scientific, UK). RNA integrity
was analyzed using the Bioanalyzer (Agilent, UK). A 50 ng
aliquot of RNA per sample was reverse transcribed to cDNA
using High-Capacity RNA-to-cDNA™ Kit. Expressions of
MCP-1, IL-6 and IL-8 were analyzed using probes from the
Universal Probe Library (UPL, Roche). Actin beta (ACTB),
Selenocysteine lyase (SCLY) and tRNA-yW synthesizing
protein 1 homolog (TYW1) were used as reference genes (for
primer sequence and probe selection, see supplementary
material, Tables S1 and S2). Assays were designed following
instructions from the Universal Probe Library Assay Design
Centre.25 Quantitative PCR (qPCR) was performed using
TaqMan Universal PCR Master Mix, following manufacturer's
protocol. Each 10 μL reaction contained 0.2 μM forward primer
and reverse primer and 0.1 μM UPL probe. cDNA was diluted
10-fold, and 4 μL of diluted cDNA was used per reaction. qPCR
was performed on Applied Biosystems 7900HT Real-Time PCR
System under the following cycling conditions: 50 °C for 2 min,
95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and
60 °C for 1 min. Data were collected at the end of each cycle.
Data analysis
All data were expressed as their mean ± standard deviation (SD)
at N = 3. The N numbers were independent experiments; each N
number had three data points (three wells). Statistical analysis of the
data was performed using Levine's homogeneity test before
statistical significance between the sample groups was assessed by
one way analysis of variance (ANOVA) tests with post-hoc Tukey
analysis in Origin 2016 (Silverdale scientific ltd, UK). Statistically
significant differences were identified when P ≤ 0.05.Results
Aggregate characterization in cell culture media
Dynamic light scattering size analysis, zeta potential, atomic
force microscopy (AFM) imaging and fluorescence spectroscopy
measurements of the aggregates in 20% ethanol, 80% water,
150 mM Trizma®, pH 7.4 vehicles are reported in the
supplementary material (See supplementary material, Figures
S1-S4).11,12 The characterization data showed (+) α-T produced
spherical liposomes (563 ± 1 nm, −10.5 ± 0.2 mV), (+) α-TP
produced planar bilayer fragments (175 nm ± 21 nm, −14.9 ±
3.5 mV) and (±) α-TP produced spherical liposomes (104 nm ±
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Figure 1. The size changes of stereo-pure alpha tocopheryl phosphate ((+) Alpha TP) (3 mM) (A), (+) alpha tocopherol ((+) Alpha T) (3 mM) (A) and racemic
alpha tocopheryl phosphate ((±) Alpha TP) (B) in either Dulbecco's Modified Eagle's Medium (DMEM) or Roswell Park Memorial Institute (RPMI) 1640
medium to show the introduction of the phosphate group facilitates aggregate swelling. Data represented mean ± standard deviation, n = 3.
4 R.A. Harper et al / Nanomedicine: Nanotechnology, Biology, and Medicine 21 (2019) 1020101.3 nm, −38.7 ± 7.0 mV) in an 20% ethanol 80% Trizma®
buffer vehicle. The (+) α-TP nanomaterials size was shown to
increase into the micron range when aliquoted into both the
DMEM and RPMI cell culture media, with no statistically
significant difference in the aggregate sizes between the two
media (P N 0.05) (24.0 ± 4.9 μm and 28.52 ± 6.46 μm at
15 min). The (+) α-T aggregates swelled in both DMEM and
RPMI over a period of 15 min to sizes of 3.7 ± 0.7 μm and
3.8 ± 0.6 μm respectively, but unlike (+) α-TP this size did not
change beyond the 15 min time point. The (±) α-TP isomer
immediately swelled to a size of 35 ± 10 μm in DMEM and
16 ± 9 μm in RPMI and then the size started to reduce upon
further incubation (Figure 1, B). It was not possible to gain clear
images of the swelled aggregates in the cell culture media.
HGF-1 cellular response to the tocopherol aggregates
(+) α-TP was well tolerated by HGF-1 cells until a
concentration of 5 mM (0.25% w/v) at which point the cell
viability significantly dropped to 75.5% ± 7.9% (Figure 2). Both
the (±) and the (+) α-TP isomers (500 μM) were found to have
the same effects on cell viability (P N 0.05), which suggested
that the stereochemistry was not a factor in the cell toxicity. At
5 mM (+) α-T did not reduce the cell viability (96.7% ± 6.1%),
which showed that the addition of the phosphate group
significantly increased the agents' cell toxicity.
When treated with heat killed bacteria from human saliva,
HFG-1 cells demonstrated a significant increase in secretion of
MCP-1 (673.5 ± 133 pg/mL, Figure 3, A) as compared to the
cells only treated with media (21.6 ± 15.6 pg/mL). (+) α-T and
(±) α-TP (500 μM) did not significantly inhibit MCP-1
production (α-T −619 ± 63 pg/mL, P N 0.05, (±) α-TP
−568 ± 107 pg/mL, P N 0.05). However, (+) α-TP (500 μM)
did significantly reduce MCP-1 production (463.9 ± 68.9 pg/mL,
P = 0.007). IL-8 (8601 ± 600 pg/mL) and IL-6 (18,310 ±
896 pg/mL) were also produced in response the heat treated
bacteria, but none of the tocopherol test agents were found to have
an inhibitory effect on their production (See supplementary
material, Figure S5).The pre-treatment of the HGF-1 cells with (+) α-TP before
inflammatory stimulation did not significantly reduce the mRNA
transcription of MCP-1, IL-6 or IL-8 compared to the heat killed
bacteria treated cells (P N 0.05, see supplementary material,
Figure S6).
THP-1 macrophage cellular response to the aggregates
(+) α-TP was less well tolerated by the differentiated THP-1
monocytes (macrophages) compared to the HGF-1 cells
(Figure 4). Macrophages treated with 500 μM of the (±) α-TP
and (+) α-TP isomers were found to only retain 7.7% ± 4.6%
(data not in figure) and 20.0% ± 4.4% viability (Figure 4),
respectively. The (+) α-TP LD50 against the macrophages was
calculated to be 304 μM. As seen with the HGF-1 cells, (+) α-T
(5 mM) was well tolerated by the THP-1 macrophages. Both
CHX and CPC, found in commercially available mouthwash
products, showed a lower LD50 value compared to (+) α-TP
(Supplementary data, Figure S7), which suggested that (+) α-TP
was better tolerated than CHX and CPC.
THP-1 macrophages treated with the negative control (media)
produced 6.0 ± 2.9 pg/mL of MCP-1 while the macrophages
treated with heat killed bacteria generated 57.3 ± 18.1 pg/mL
MCP-1 (Figure 5). (+) α-T (500 μM), which was not toxic to
macrophages, was not found to inhibit MCP-1 generated from the
THP-1 macrophages (55.3 ± 31.7 pg/mL). Cells treated with (±)
and (+) α-TP (500 μM),whichwere toxic tomacrophages, resulted
in very low levels of MCP-1 secretion (16.1 ± 5.1 pg/mL for (±)
isomer and 6.5 ± 3.2 pg/mL for (+) isomer, P = 0.003) ((+)
isomer,P N 0.05with media control). Non-toxic concentrations of
(±) or (+) α-TP did not inhibit MCP-1 production from the
macrophage cells.Discussion
The tocopherol nanomaterials tested in this work swelled
when spiked into cell culture media. The different swelling
profiles observed for the nanomaterials in the DMEM and RPMI
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Figure 2. Human gingival fibroblast cell (HGF-1) viability upon tocopheryl
application showing good tolerability to the test compounds. Cells treated
with (+) alpha tocopheryl phosphate (alpha TP), (±) alpha TP or alpha
tocopheryl (alpha T) diluted in Dulbecco's modified Eagle's cell culture
medium (without FBS) at 37 °C for 4 h. Data represented mean ± standard
deviation, n = 3.
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Figure 3. Tocopherol inhibition of monocyte chemoattractant protein-1
(MCP-1) secreted from human gingival fibroblast cells showing (+) alpha TP
was the only sample that produced a statistically significant reduction from
the positive control. Cells pre-incubated with (+) alpha tocopheryl phosphate
(alpha TP), (±) alpha TP or (+) alpha tocopherol (alpha T) samples for 4 h
followed by 15 h exposure to inflammatory stimuli. Data represented
mean ± standard deviation, n = 3. N.B. No change in cell morphology was
noted by phase contrast.
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composition. The iron, which was only present in the DMEM,
was identified as the most likely component to explain the
differential behavior, as it is known to interact with phosphor-
ylated compounds.26 In both media the swelling of the
nanomaterials was attributed to a transition of the lipid
aggregates to multi-lamella liposomes due to the change of
ionic strength in the dispersion media.11 An alternative
explanation to the observed size changes was that the
nanomaterials were aggregating. However, this was thought to
be unlikely as the dispersions changed size with a high degree of
reproducibility, which is not common in aggregated systems.27
Unlike macrophages, non-phagocytic cells are unlikely to
internalize the micron sized carriers; hence, the changes in
nanomaterial characteristics in physiological fluids were thought
to be beneficial for macrophage targeting. This hypothesis was
supported by the cell cytotoxicity and cytokine suppression data
discussed further below.
The (+) α-TP reduced MCP-1 production by HGF-1 cells
exposed to heat killed bacteria by approximately 32%. In the
literature there does not seem to be a report that has previously
shown that α-TP can suppress MCP-1 release. The anti-
inflammatory agent, Bindarit, which has some structural
similarities to α-TP, has previously been shown to selectively
inhibit MCP-1 through the inhibition of MCP-1 mRNA, but in
this work (+) α-TP was found not to inhibit mRNA transcript
expression. From the lack of MCP-1 mRNA inhibition it could
be deduced that (+) α-TP influenced post mRNA transcription
activity such as protein synthesis or cellular protein secretion
inhibition. However, because the cell signaling pathways for the
heat treated saliva induced cytokine release from HGF-1 cells
have not been well established the (+) alpha-TP mechanism of
action was not investigated further28It was surprising that all the tocopherols used in this work did
not inhibit cytokine release from the cell lines because (+) α-T has
previously been shown to have anti-inflammatory effects.29–31 In
addition, (+) α-T has been observed to inhibit IL-6 from HGF-1
cells in the literature.32 However, in previous work LPS from P.
gingivalis was used to induce the cytokine and in this study heat
killed bacteria from human saliva were used. It is possible that
the tocopherols inhibit cytokine production on the LPS
stimulation pathway and not other salivary inflammatory stimuli
pathways.
The selective α-TP toxicity and subsequent reduction in
MCP-1 secretion from THP-1 macrophages were thought to be a
function of the nanomaterial swelling. The most selective of the
aggregates in terms of α-TP toxicity and MCP-1 suppression was
(+) α-TP followed by (±) α-TP then (+) α-T, which was not toxic
and did not suppress MCP-1. This rank order aligned to the sizes
of the aggregates when presented to the cells. This could, at least
in part, be a consequence of greater internalization of the larger
aggregates due to more material volume being phagocytized by
individual macrophages.33 Selective macrophage toxicity of α-
TP was thought to be desirable for the treatment of the chronic
inflammatory phase of periodontal disease as it could control the
macrophage burden and shorten the immune response.34
However, it is not desirable to kill all macrophages as they
perform a beneficial role of engulfing microbes and preventing
the spread of systemic infection. In this aspect it was promising
that even though (+) α-TP showed selective toxicity towards the
macrophages it was still found to be less toxic (lower LD50
values) than two commercially used antimicrobial agents CHX
and CPC; suggesting that it was capable of regulating
macrophage accumulation without complete depletion.
0.5 5 50 500 5000
0
20
40
60
80
100
120
140
160
180
)
%(
ytilibaiVlle
C
(+) Alpha tocopheryl phosphate concentration ( µM)
Lethal Dose 50%
304 µM
Figure 4. (+) alpha tocopheryl phosphate toxicity to THP-1 macrophages
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Figure 5. Tocopherol inhibition of monocyte chemoattractant protein (MCP-
1) secretion from THP-1 macrophages related to cell viability showing that
cell death inhibited MCP-1 release. Cells were pre-incubated with (+) alpha
tocopheryl phosphate (alpha TP), (±) alpha TP or alpha tocopherol (alpha T).
Data represented mean ± standard deviation, n = 3. N.B. No change in cell
morphology was noted by phase contrast.
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Mild and moderate periodontitis affects the majority of the
adult global population with 10.5%-12% of the population
affected by severe periodontitis, making it the sixth most
prevalent condition in 2010.35 However, at present, sub-
antimicrobial dose doxycycline is the only agent that has been
approved for human use that inhibits the gingival inflammatory
process, the cause of the destructive elements of this disease.36 (+)α-TP has previously been shown to be tooth adherent, substantive,
and capable of reducing the oral microbial burden.11,12 In this
study the swelling of (+) α-TP nano-sized aggregates was shown to
have an anti-inflammatory effect on macrophages by selective
macrophage toxicity thereby reducing MCP-1 generation. This
effect would then dampen excessive macrophage burden and
therefore reduce gingival destruction making this compound an
attractive prospect for development as a multifunctional agent to
improve oral health.Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.nano.2019.04.013.
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